Anticholinergic burden tied to adverse effects in middle age
(HealthDay)—Anticholinergic burden (ACB) is associated with adverse outcomes in a middle- to older-aged population, according to a study published in the March/April issue of the Annals of Family Medicine.
Mar 11, 2020
0
2
